Detalles de la búsqueda
1.
Veliparib with frontline chemotherapy and as maintenance in Japanese women with ovarian cancer: a subanalysis of efficacy, safety, and antiemetic use in the phase 3 VELIA trial.
Int J Clin Oncol
; 28(1): 163-174, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36534262
2.
Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer.
N Engl J Med
; 381(25): 2403-2415, 2019 12 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-31562800
3.
Impact of veliparib, paclitaxel dosing regimen, and germline BRCA status on the primary treatment of serous ovarian cancer - an ancillary data analysis of the VELIA trial.
Gynecol Oncol
; 164(2): 278-287, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34930617
4.
Progression-free survival by investigator versus blinded independent central review in newly diagnosed patients with high-grade serous ovarian cancer: Analysis of the VELIA/GOG-3005 trial.
Gynecol Oncol
; 162(2): 375-381, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34112513
5.
Veliparib with carboplatin and paclitaxel in BRCA-mutated advanced breast cancer (BROCADE3): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol
; 21(10): 1269-1282, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32861273
6.
A first-in-human, phase 1, dose-escalation study of ABBV-176, an antibody-drug conjugate targeting the prolactin receptor, in patients with advanced solid tumors.
Invest New Drugs
; 38(6): 1815-1825, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32524319
7.
A phase 1 study of PARP-inhibitor ABT-767 in advanced solid tumors with BRCA1/2 mutations and high-grade serous ovarian, fallopian tube, or primary peritoneal cancer.
Invest New Drugs
; 36(5): 828-835, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29313279
8.
Veliparib with carboplatin and paclitaxel in BRCA-mutated advanced breast cancer (BROCADE3): Final overall survival results from a randomized phase 3 trial.
Eur J Cancer
; 200: 113580, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38309017
9.
Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met Protein-Overexpressing Advanced Non-Squamous EGFR-Wildtype NSCLC in the Phase 2 LUMINOSITY Trial.
J Clin Oncol
; : JCO2400720, 2024 Jun 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38843488
10.
TAK1 targeting by glucocorticoids determines JNK and IkappaB regulation in Toll-like receptor-stimulated macrophages.
Blood
; 115(10): 1921-31, 2010 Mar 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-20065289
11.
Generation of myometrium-specific Bmal1 knockout mice for parturition analysis.
Reprod Fertil Dev
; 24(5): 759-67, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22697126
12.
Exposure-Response Model With Time-Varying Predictors to Estimate the Effects of Veliparib in Combination With Carboplatin/Paclitaxel and as Monotherapy: Veliparib Phase 3 Study in BRCA-Mutated Advanced Breast Cancer (BROCADE3) Trial.
J Clin Pharmacol
; 62(10): 1236-1246, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35403245
13.
Safety and efficacy of veliparib plus carboplatin/paclitaxel in patients with HER2-negative metastatic or locally advanced breast cancer: subgroup analyses by germline BRCA1/2 mutations and hormone receptor status from the phase-3 BROCADE3 trial.
Ther Adv Med Oncol
; 13: 17588359211059601, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34917174
14.
Efficacy and safety of first-line veliparib and carboplatin-paclitaxel in patients with HER2- advanced germline BRCA+ breast cancer: Subgroup analysis of a randomised clinical trial.
Eur J Cancer
; 154: 35-45, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34243076
15.
Relevance of Platinum-free Interval and BRCA Reversion Mutations for Veliparib Monotherapy after Progression on Carboplatin/Paclitaxel for gBRCA Advanced Breast Cancer (BROCADE3 Crossover).
Clin Cancer Res
; 27(18): 4983-4993, 2021 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34131001
16.
Clock gene expression in gravid uterus and extra-embryonic tissues during late gestation in the mouse.
Reprod Fertil Dev
; 22(5): 743-50, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-20450826
17.
Exposure-response analysis to inform the optimal dose of veliparib in combination with carboplatin and paclitaxel in BRCA-mutated advanced breast cancer patients.
Cancer Chemother Pharmacol
; 84(5): 977-986, 2019 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-31468137
18.
Insights into parturition biology from genetically altered mice.
Pediatr Res
; 64(6): 581-9, 2008 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-18679156
19.
Hypoxia regulates the expression of fatty acid-binding proteins in primary term human trophoblasts.
Am J Obstet Gynecol
; 197(5): 516.e1-6, 2007 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-17826730
20.
Preventing preterm birth: the past limitations and new potential of animal models.
Dis Model Mech
; 3(7-8): 407-14, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-20610693